Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor

Clinical Cancer Research

Volumn 7, Issue 5, 2001, Pages 1459-1465

  Ciardiello, Fortunato ^a   Caputo, Rosa ^a   Bianco, Roberto ^a   Damiano, Vincenzo ^a   Fontanini, Gabriella ^b   Cuccato, Sabina ^b   De Placido, Sabino ^b   Bianco, A Raffaele ^a   Tortora, Giampaolo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; GEFITINIB; GROWTH FACTOR; PACLITAXEL; PROTEIN TYROSINE KINASE INHIBITOR; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOCRINE EFFECT; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG POTENTIATION; DRUG SELECTIVITY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; PARACRINE SIGNALING; PRIORITY JOURNAL;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 2; GROWTH SUBSTANCES; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITORY CONCENTRATION 50; LYMPHOKINES; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN-TYROSINE KINASES; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0034896362     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Autocrine secretion: 10 Years later
2. Tumor angiogenesis
3. Regulation of angiogenesis
4. The fibroblast growth factor family
5. Molecular and biological properties of the vascular endothelial growth factor family of proteins
6. The role of vascular endothelial growth factor in pathological angiogenesis
7. Clinical applications of research on angiogenesis
8. Clinical implications of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool
9. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma
10. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastasis and survival in breast cancer
11. Relation of neovascularization to metastasis of non-small-cell lung cancer
12. Epidermal growth factor-related peptides and their receptors in human malignancies
13. The epidermal growth factor receptor and its inhibition in cancer therapy
14. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: A model of glioblastoma multiforme pathophysiology
15. Transforming growth factor α-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP2-dependent DNA binding and transactivation
16. Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A
17. Neutralizing antibodies against epidermal growth factor and erbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo
18. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice
19. Anticancer drug targets: Growth factors and growth factor signaling
20. Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily
21. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor
22. Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: Amphiregulin and microvessel count are independent prognostic indicators of survival
23. Growth inhibition of human colon carcinoma cells by combinations of anti-EGF-related growth factor antisense oligonucleotides
24. Anti-angiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells
25. The microtubule-affecting drug paclitaxel has antiangiogenic activity
26. Type I receptor tyrosine kinases as targets for therapy in breast cancer
27. Therapeutic application of antigrowth factor receptor antibodies
28. Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms
29. Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma